|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 | |||
| C07K 14/51 | |||
| G01N 33/53 | |||
| A61P 19/10 |
| (11) | Number of the document | 1636270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04776553.2 |
| Date of filing the European patent application | 2004-06-15 | |
| (97) | Date of publication of the European application | 2006-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/018912 |
| Date | 2004-06-15 |
| (87) | Number | WO 2005/014650 |
| Date | 2005-02-17 |
| (30) | Number | Date | Country code |
| 478977 P | 2003-06-16 | US |
| (72) |
WINKLER, David, G., US
SHI, Jiye, US
LATHAM, John, US
|
| (73) |
UCB Pharma S.A.,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION |
| ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION |